Literature DB >> 15686994

Sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of paracetamol and guaifenesin in human plasma.

Xiaoyan Chen1, Jia Huang, Zhang Kong, Dafang Zhong.   

Abstract

A rapid and sensitive method for the simultaneous determination of paracetamol and guaifenesin in human plasma was developed and validated, using high-performance liquid chromatographic separation with tandem mass spectrometric detection. After extracted from plasma samples by diethyl ether-dichloromethane (3:2, v/v), the analytes and internal standard osalmide were chromatographed on a C18 column. Detection was performed on a triple quadrupole tandem mass spectrometer by selected reaction monitoring (SRM) mode via atmospheric pressure chemical ionization (APCI). The method was linear in the concentration range of 0.05-20.0 microg/ml for paracetamol and 5.0-2000.0 ng/ml for guaifenesin. The intra- and inter-day precision was within 14% for both paracetamol and guaifenesin. The assay accuracy was within +/-2.4% for the analytes. This is the first assay method described for the simultaneous determination of paracetamol and guaifenesin in plasma using one chromatographic run. The method was successfully employed in a pharmacokinetic study after an oral administration of a multicomponent formulation, containing 650 mg paracetamol, 200 mg guaifenesin, 60 mg pseudoephedrine and 20 mg dextrorphan.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686994     DOI: 10.1016/j.jchromb.2004.12.011

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol.

Authors:  Trevor Tanner; Sue Aspley; Andrew Munn; Tracy Thomas
Journal:  BMC Clin Pharmacol       Date:  2010-07-05

2.  Quantitation of paracetamol by liquid chromatography-mass spectrometry in human plasma in support of clinical trial.

Authors:  Richard Kin-Ting Kam; Michael Ho-Ming Chan; Hiu-Ting Wong; Aniruddha Ghose; Arjen M Dondorp; Katherine Plewes; Joel Tarning
Journal:  Future Sci OA       Date:  2018-08-15

3.  Eco-friendly UPLC-MS/MS analysis of possible add-on therapy for COVID-19 in human plasma: Insights of greenness assessment.

Authors:  Omnia A El-Naem; Sarah S Saleh
Journal:  Microchem J       Date:  2021-04-02       Impact factor: 4.821

4.  Development and validation of stability indicating the RP-HPLC method for the estimation of related compounds of guaifenesin in pharmaceutical dosage forms.

Authors:  Sunil Pingili Reddy; K Sudhakar Babu; Navneet Kumar; Y V V Sasi Sekhar
Journal:  Pharm Methods       Date:  2011-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.